Your browser doesn't support javascript.
loading
Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.
Finazzi, T; Rordorf, T; Ikenberg, K; Huber, G F; Guckenberger, M; Garcia Schueler, H I.
Afiliação
  • Finazzi T; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
  • Rordorf T; Department of Oncology, University Hospital Zurich, Zurich, Switzerland.
  • Ikenberg K; Department of Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Huber GF; Department of Otorhinolaryngology, University Hospital Zurich, Zurich, Switzerland.
  • Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
  • Garcia Schueler HI; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. helena.garcia@usz.ch.
BMC Cancer ; 18(1): 395, 2018 04 06.
Article em En | MEDLINE | ID: mdl-29625593
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Antineoplásicos Imunológicos / Carcinoma Nasofaríngeo Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Antineoplásicos Imunológicos / Carcinoma Nasofaríngeo Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article